Business

RAD Announces 50% Enrollment in Phase 2b Trial of RAD101

RAD Announces 50% Enrollment in Phase 2b Trial of RAD101

Radiopharm Theranostics LimitedNovember 16, 20254

RAD Announces 50% Enrollment in Phase 2b Trial of RAD101

About this update from Radiopharm Theranostics Limited

Radiopharm Theranostics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Radiopharm Theranostics Limited

More from Radiopharm Theranostics Limited

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202...

August 20, 2026

RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial

August 19, 2026

All Radiopharm Theranostics Limited news →